Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-24

FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) submitted by Janssen Pharmaceuticals, Inc. The snippet doe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Invokamet (canagliflozin and metformin hydrochloride)

Snippet

SUPPL AP for INVOKAMET (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)